Primitive Neuroectodermal Tumors. State of Art
Main Article Content
Abstract
PNETs, also known as primitive neuroectodermal tumors, are extremely uncommon sarcomas that originate from the neural crest. It has been observed that the yearly incidence of these instances is 2.9 cases per million people between the ages of birth and 20.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Wu, Y., Ji, H., Zhang, S., Zhang, Y., Chu, W., Mei, Y., ... & Zhang, B. (2021). Primary primitive neuroectodermal tumor of urinary bladder: a case report and literature review. Translational Cancer Research, 10(11), 4997.
II. Patil, A., Gupta, P., & Iratwar, S. (2021). Primary spinal extradural extraosseous primitive neuroectodermal tumor/Ewing's sarcoma: A critical analysis and review. Asian Journal of Neurosurgery, 16(02), 276-280.
III. Wei, X., Zhang, X., Song, Z., & Wang, F. (2021). Analysis of clinical, imaging, and pathologic features of 36 patients with primary intraspinal primitive neuroectodermal tumors: a case series and literature review. Journal of Neurological Surgery Part A: Central European Neurosurgery, 82(06), 526-537.
IV. Deshpande, G., Epari, S., Gupta, C., Shetty, O., Gurav, M., Chinnaswamy, G., ... & Gupta, T. (2021). Primary intracranial Ewing sarcoma/peripheral primitive neuroectodermal tumor, an entity of unacquaintance: a series of 8 cases. Child's Nervous System, 37, 839-849.
V. Liu, Y., Yuan, Y., Zhang, F., Hu, K., Qiu, J., Hou, X., ... & Shen, J. (2020). Outcome of multidisciplinary treatment of peripheral primitive neuroectodermal tumor. Scientific Reports, 10(1), 15656.
VI. Schniederjan, M. J., Shehata, B., Brat, D. J., Esiashvili, N., & Janss, A. J. (2009). De novo germline TP53 mutation presenting with synchronous malignancies of the central nervous system. Pediatric blood & cancer, 53(7), 1352-1354.
VII. Esiashvili, N., Goodman, M., Ward, K., Marcus Jr, R. B., & Johnstone, P. A. (2007). Neuroblastoma in adults: incidence and survival analysis based on SEER data. Pediatric blood & cancer, 49(1), 41-46.